What are the clinical manifestations of Wolff-Parkinson-White (WPW) syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Clinical Manifestations of Wolff-Parkinson-White Syndrome

Wolff-Parkinson-White syndrome can present with a spectrum of clinical manifestations ranging from asymptomatic pre-excitation to life-threatening arrhythmias, with sudden cardiac death occurring at a rate of approximately 0.15% per year due to atrial fibrillation degenerating into ventricular fibrillation. 1

Electrocardiographic Features

The classic ECG findings in WPW syndrome include:

  • PR interval less than 0.12 seconds
  • Delta wave (slurring of initial segment of QRS complex)
  • QRS complex widening (duration greater than 0.12 seconds)
  • Secondary repolarization changes (ST segment-T wave changes directed opposite to delta wave) 2

Symptomatic Presentations

Tachyarrhythmias

  • Atrioventricular reentrant tachycardia (AVRT): Most common arrhythmia in WPW syndrome
  • Pre-excited atrial fibrillation: Occurs in up to 50% of patients with WPW 3
  • Atrial flutter
  • Ventricular fibrillation: Most serious complication, can lead to sudden cardiac death

Symptoms During Arrhythmic Episodes

  • Palpitations
  • Dizziness
  • Presyncope
  • Syncope
  • Chest discomfort
  • Dyspnea
  • Anxiety
  • Diaphoresis
  • Fatigue
  • Polyuria (due to atrial natriuretic peptide release during tachycardia)

Asymptomatic Presentation

Approximately 50% of patients with WPW ECG pattern have no history of arrhythmias 1. However, it's important to note that sudden cardiac death may be the first manifestation of the disease in some patients.

Risk Factors for Sudden Cardiac Death

Patients at higher risk for sudden cardiac death typically demonstrate:

  • History of symptomatic tachycardia
  • Short RR intervals (<250 ms) between pre-excited beats during atrial fibrillation
  • Multiple accessory pathways
  • Posteroseptally located pathways 1, 4

Associated Conditions

While most patients with WPW syndrome have normal cardiac anatomy, it may be associated with:

  • Ebstein's anomaly (2-4% of cases)
  • Other congenital heart diseases
  • Systemic diseases 5

Reduced Exercise Capacity

For some specific locations of accessory pathways with overt anterograde conduction, there might be:

  • Reduction in exercise capacity
  • Decreased LV systolic performance due to anomalous LV depolarization 5

Age and Sex Distribution

WPW syndrome affects approximately 0.1-0.3% of the general population 5, 2. It is more common in males, with studies showing male preponderance (63%) among asymptomatic patients 1.

Clinical Course

The natural history of WPW syndrome varies:

  • In observational cohorts of asymptomatic patients who did not undergo catheter ablation:

    • Regular supraventricular tachycardia or benign atrial fibrillation develops in 0-16%
    • Malignant atrial fibrillation develops in 0-9%
    • Ventricular fibrillation develops in 0-2% (mostly children) 1
  • In one prospective study, 11% of initially asymptomatic patients developed arrhythmic events over a median follow-up of 67 months, with potentially life-threatening arrhythmias in 17 of these patients 1

Diagnostic Pitfalls

  • WPW pattern on ECG may mimic pseudo diaphragmatic (inferior) myocardial infarction 6
  • Intermittent pre-excitation can make diagnosis challenging
  • Pre-excited atrial fibrillation may be misdiagnosed, leading to inappropriate treatment that could induce ventricular fibrillation 3

Early recognition of WPW syndrome is crucial, as appropriate risk stratification and treatment can significantly reduce morbidity and mortality from life-threatening arrhythmias.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Wolff-Parkinson-White Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Wolff-Parkinson-White Syndrome--current views.

The American journal of medicine, 1977

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.